NCT05262621

Brief Summary

Study design A 2-arm, assessor-blinded randomised controlled trial will be conducted. The design will follow the Standard Protocol Items Recommendations for Interventional Trials (SPIRIT)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
6 days until next milestone

Study Start

First participant enrolled

March 8, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 2, 2022

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 10, 2022

Completed
Last Updated

April 12, 2023

Status Verified

April 1, 2023

Enrollment Period

5 months

First QC Date

February 9, 2022

Last Update Submit

April 11, 2023

Conditions

Keywords

music interventionprogressive muscle relaxationanxietydepressionquality of lifechemotherapybeast cancergynaecology cancer

Outcome Measures

Primary Outcomes (2)

  • Change from baseline anxiety at 3 weeks and 6 weeks

    it will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for anxiety (DASS21-A). A 4-point Likert-type scale ranging from 0 to 3 was designed for each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the anxiety score can range from 0 to 42. The higher the score is the more severe anxiety. The score of 0-7 is normal, 8-9 mild, 10-14 moderate, 15-19 severe, +20 extremely severe.

    ebaseline, T1 after 3 weeks, T2 after 6 weeks

  • Change from baseline depression at 3 weeks and 6 weeks

    it will be measured using the short form of the Depression Anxiety Stress Scale (DASS-21). It includes 7 items for depression (DASS21-D). A 4-point Likert-type scale ranging from 0 to 3 was designed on each item, and the scores will need to be multiplied by 2 to calculate the final score. Thus, the depression score can range from 0 to 42. The higher the score is the more severe depression. The score of 0-9 is normal, 10-13 mild, 14-20 moderate, 21-27 severe, +28 extremely severe.

    baseline, T1 after 3 weeks, T2 after 6 weeks

Secondary Outcomes (4)

  • Change from baseline stress at 3 weeks and 6 weeks

    baseline, T1 after 3 weeks, T2 after 6 weeks

  • Change from baseline coping styles at 3 weeks and 6 weeks

    baseline, T1 after 3 weeks, T2 after 6 weeks

  • Change from baseline quality of life at 3 weeks and 6 weeks

    baseline, T1 after 3 weeks, T2 after 6 weeks

  • Change from baseline satisfaction of nursing care at 3 weeks

    baseline, T1 after 3 weeks,

Study Arms (2)

Music intervention combined with progressive muscle relaxation

EXPERIMENTAL

Music intervention combined with progressive muscle relaxation.

Other: progressive muscle relaxationOther: Listening to relaxing music once/day

Control group

NO INTERVENTION

no music therapy will be done.

Interventions

Practice muscle relaxation for 20 minutes once/a day

Music intervention combined with progressive muscle relaxation

Right after practising progressive muscle relaxation, the participants will listen to relaxing music for 20 minutes

Music intervention combined with progressive muscle relaxation

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women with breast or gynaecological cancer are 18 years of age or older, and are independent legally to sign the consent form.
  • Living with family and having an adult family member agree to participate in the meeting part of the program.
  • Had been informed the cancer diagnosis
  • Have Karnofsky score (Mor et al., 1984) ≥ 80 ( to be able to self-practice MCP)
  • Can communicate, read and write in Vietnamese
  • Have a device such as a smartphone, MP3 to keep the audio file (to self-practice MCP at home)
  • Consent to join the study

You may not qualify if:

  • The patients cannot understand the study procedures
  • Have mental health illness, deafness, blindness
  • Have not been aware of their cancer or the purpose of chemotherapy
  • Be participating in other studies related to psychological issues
  • Be receiving anxiety or depression treatment.
  • Be participating in relaxation therapy such as yoga, meditation, mindfulness, PMR...
  • Have a potential treatment (eg. surgery) or personal plans that will prevent them from practising daily during the 6 weeks of the intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vietnam National Cancer Institute, Hanoi Oncology Hospital

Hanoi, 134000, Vietnam

Location

Related Publications (2)

  • Nguyen KT, Chan DNS, Cheung AT, Hoang HTX, Truong AT, Chow KM, Choi KC, Chan CWH. Randomised controlled trial of music listening combined with progressive muscle relaxation for mood management in women receiving chemotherapy for cancer. Support Care Cancer. 2025 Mar 4;33(3):245. doi: 10.1007/s00520-025-09281-4.

  • Nguyen KT, Hoang HTX, Bui QV, Chan DNS, Choi KC, Chan CWH. Effects of music intervention combined with progressive muscle relaxation on anxiety, depression, stress and quality of life among women with cancer receiving chemotherapy: A pilot randomized controlled trial. PLoS One. 2023 Nov 3;18(11):e0293060. doi: 10.1371/journal.pone.0293060. eCollection 2023.

MeSH Terms

Conditions

NeoplasmsAnxiety DisordersDepression

Interventions

Autogenic Training

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

HypnosisMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Khanh Thi Nguyen, master

    The Nethersole School of Nursing, The Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The research assistants who assess outcome data, data entry and analysis will be blinded to avoid the risk of assessor bias. The assistants will not participate in any other stage of implementing the program.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 9, 2022

First Posted

March 2, 2022

Study Start

March 8, 2022

Primary Completion

August 2, 2022

Study Completion

August 10, 2022

Last Updated

April 12, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations